Physician
Bakersfield Pathology Medical Group
Bakersfield Pathology Medical Group was paid $229K by Medicaid between Jan 2018 and Nov 2020, across 82 billing codes. Its largest line is 80053, Comprehensive metabolic panel — 17% of everything it billed.
33Billing provider infoBAKERSFIELD PATHOLOGY MEDICAL GROUP
BAKERSFIELD, CA 93301
BAKERSFIELD, CA 93301
33aNPI1114996345assigned 03/17/2006
33bProvider typeCytopathology Physician
28Total paid$229K
24GClaims117,548
24DCodes billed82
24AFirst – last monthJan 2018 – Nov 2020
Compared with peers
Next to other Cytopathology Physician providers in California
Rank by total paid#23 of 69
Median peer was paid$50K
This provider vs. median4.6×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 31,703 | $42K | |
| 2019 | 30,719 | $39K | |
| 2020 | 55,126 | $149K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 80053 | Comprehensive metabolic panel | 17% | 13,406 | 10,813 | $40K |
| 88307 | 12% | 369 | 365 | $27K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 9.3% | 20,163 | 13,875 | $21K |
| 88304 | 6.3% | 599 | 595 | $14K | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 5.7% | 385 | 377 | $13K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 5.3% | 1,092 | 988 | $12K |
| 80048 | Basic metabolic panel (calcium, ionized) | 4.1% | 5,863 | 2,419 | $9K |
| 83880 | 4.0% | 2,337 | 2,074 | $9K | |
| 83735 | 2.9% | 7,537 | 3,212 | $7K | |
| 84443 | Thyroid stimulating hormone (TSH) | 2.6% | 1,883 | 1,847 | $6K |
| 84484 | 2.2% | 4,257 | 3,575 | $5K | |
| 81001 | 2.1% | 8,765 | 8,144 | $5K |
70 more codes
| 80061 | Lipid panel | 1.8% | 2,031 | $4K |
| 83690 | 1.6% | 4,420 | $4K | |
| 83605 | 1.6% | 2,901 | $4K | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 1.5% | 341 | $3K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 1.4% | 290 | $3K |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | 1.4% | 1,566 | $3K |
| 81025 | 1.3% | 1,081 | $3K | |
| 85730 | 1.1% | 2,911 | $2K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 1,577 | $2K |
| 87040 | <1% | 1,836 | $2K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 1,933 | $2K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 888 | $2K |
| 85379 | <1% | 1,345 | $2K | |
| 82948 | <1% | 4,297 | $2K | |
| 86780 | <1% | 1,306 | $2K | |
| 82805 | <1% | 497 | $2K | |
| 85610 | <1% | 2,986 | $1K | |
| 87081 | <1% | 1,243 | $1K | |
| 86803 | <1% | 1,117 | $1K | |
| 80074 | <1% | 118 | $1K | |
| 86769 | <1% | 65 | $1K | |
| 87400 | <1% | 756 | $968.01 | |
| 80076 | <1% | 716 | $740.74 | |
| 87186 | <1% | 609 | $724.64 | |
| 84100 | <1% | 1,582 | $693.04 | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 564 | $681.77 |
| 85027 | <1% | 1,009 | $670.01 | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 98 | $657.51 |
| 82150 | <1% | 594 | $638.61 | |
| 87077 | <1% | 516 | $621.58 | |
| 86592 | <1% | 260 | $597.70 | |
| 84702 | <1% | 1,143 | $515.00 | |
| 80050 | General health panel | <1% | 725 | $480.63 |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 98 | $466.11 |
| 86140 | <1% | 755 | $430.08 | |
| 82550 | <1% | 703 | $390.61 | |
| 80202 | <1% | 220 | $377.38 | |
| 84439 | <1% | 231 | $354.66 | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 67 | $325.26 |
| 85007 | <1% | 956 | $318.79 | |
| 87070 | <1% | 270 | $258.56 | |
| 86635 | <1% | 192 | $245.76 | |
| 84145 | <1% | 174 | $218.11 | |
| 87486 | <1% | 46 | $205.26 | |
| 87581 | <1% | 45 | $201.41 | |
| 87205 | <1% | 340 | $201.25 | |
| 87807 | <1% | 106 | $167.21 | |
| 82140 | <1% | 91 | $160.14 | |
| 82247 | <1% | 231 | $150.87 | |
| 82248 | <1% | 367 | $131.11 | |
| 86038 | <1% | 52 | $105.69 | |
| 86141 | <1% | 59 | $83.78 | |
| 83615 | <1% | 333 | $80.82 | |
| 86701 | <1% | 20 | $80.04 | |
| 82728 | <1% | 206 | $73.35 | |
| 82043 | <1% | 73 | $72.04 | |
| 84703 | <1% | 226 | $57.20 | |
| 82010 | <1% | 46 | $53.69 | |
| 84481 | <1% | 13 | $46.80 | |
| 85652 | <1% | 138 | $40.97 | |
| 85651 | <1% | 43 | $32.82 | |
| 85018 | <1% | 99 | $30.58 | |
| 85014 | <1% | 87 | $24.91 | |
| 82553 | <1% | 15 | $15.04 | |
| 36415 | Collection of venous blood by venipuncture | <1% | 1,163 | $12.36 |
| 84466 | <1% | 15 | $11.88 | |
| 82570 | <1% | 14 | $9.23 | |
| 87340 | <1% | 13 | $6.56 | |
| 85384 | <1% | 24 | $1.38 | |
| 84132 | 0% | 40 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialGUINTO-MIRANDA, LILIBETH (PRESIDENT)
| Provider | Location | Paid |
|---|---|---|
| Bakersfield Pathology Medical Group | Bakersfield, CA | $50K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.